Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Guilin Sanjin Of China Seeks To Be First To Try IPO In Nine Months

This article was originally published in PharmAsia News

Executive Summary

China's Guilin Sanjin Pharmaceutical is busy promoting itself to potential institutional investors as it attempts to be the nation's first company to go public in nine months. Guilin Sanjin is launching an initial public offering, now free to do so after regulators lifted a freeze on IPOs as of June 18. The medium-size drug maker seeks to raise nearly $93 million by going public. (Click here for more
UsernamePublicRestriction

Register

SC071996

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel